Home » Topics » BioWorld Science

BioWorld Science
RSS

Penciling in the right base corrects progeria mutation

Jan. 8, 2021

Pfizer and CTxT Pty synthesize KAT inhibitors

Jan. 8, 2021

LY-CoV555 does not show efficacy in hospitalized patients with COVID-19

Jan. 8, 2021

GlaxoSmithKline plc discloses new antibacterials

Jan. 8, 2021

Chinese researchers presents new SERCAs for breast cancer

Jan. 8, 2021

Beijing Reciproca Pharmaceuticals patents new CDK inhibitors

Jan. 8, 2021

REGENXBIO announces development updates for RGX-314 and RGX-202

Jan. 8, 2021

FDA approves IND for phase IIb study of orismilast in patients with plaque psoriasis

Jan. 8, 2021

HELIOS-A phase III study of vutrisiran meets its primary and secondary endpoints

Jan. 8, 2021

Topline data presented from phase III KEEPsAKE studies of risankizumab

Jan. 8, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...